He wanted to stay in the laboratory. A reluctant move into business led to nineteen years running Alnylam - and a new chapter building companies, backing founders, and knowing when to hand over the keys.

The City Therapeutics CEO has spent a career translating new science into organizations that can move - with a bias for shared purpose, quick decisions and the unglamorous work that follows discovery.